Ben joined Frazier Healthcare Partners in 2006. He represents Frazier on the boards of CSafe Global, Caravel Autism Health, Comprehensive Pharmacy Services, Matrix Medical Network, Parata Systems, and United Derm Partners. Ben has been responsible for Frazier’s successful investments in Ascension Orthopedics (acquired by Integra Lifesciences NASDAQ: IART), DSI Renal (merged with U.S. Renal Care and ultimately acquired by Bain Capital), Golden State Medical Supply (acquired by Court Square Capital Partners), Laboratory Supply Company (acquired by McKesson NYSE: MCK) and Northfield Medical (acquired by Agiliti, Inc.). He also oversees human capital recruitment for Frazier’s Growth Buyout practice.
Prior to Frazier, Ben was an Associate at Morgan Stanley Capital Partners (MSCP), focusing on investing in the healthcare sector. Before joining MSCP, he was an Analyst in the Healthcare Investment Banking Group of Morgan Stanley. Earlier, he spent time at Arthur Andersen.
Ben is also an Advisor for American Corporate Partners, a nationwide mentoring program dedicated to helping veterans transition to the private sector.
Ben received his M.B.A from the Tuck School of Business at Dartmouth and his B.B.A. in Finance and Computer Applications from the University of Notre Dame.
Tuck School of Business at Dartmouth (M.B.A.)
University of Notre Dame (B.B.A., in Finance and Computer Applications)